These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML. Loke J, Assi SA, Imperato MR, Ptasinska A, Cauchy P, Grabovska Y, Soria NM, Raghavan M, Delwel HR, Cockerill PN, Heidenreich O, Bonifer C. Cell Rep; 2017 May 23; 19(8):1654-1668. PubMed ID: 28538183 [Abstract] [Full Text] [Related]
26. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia. Fischer J, Rossetti S, Datta A, Eng K, Beghini A, Sacchi N. Mol Cancer; 2015 Jan 23; 14():7. PubMed ID: 25612891 [Abstract] [Full Text] [Related]
30. Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia. Matsuura S, Yan M, Lo MC, Ahn EY, Weng S, Dangoor D, Matin M, Higashi T, Feng GS, Zhang DE. Blood; 2012 Mar 29; 119(13):3155-63. PubMed ID: 22223820 [Abstract] [Full Text] [Related]
33. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation. Liu J, Lu W, Liu S, Wang Y, Li S, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Wang M, Wang J. Leuk Res; 2018 May 29; 68():15-21. PubMed ID: 29518627 [Abstract] [Full Text] [Related]
34. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. Fu L, Shi J, Liu A, Zhou L, Jiang M, Fu H, Xu K, Li D, Deng A, Zhang Q, Pang Y, Guo Y, Hu K, Zhou J, Wang Y, Huang W, Jing Y, Dou L, Wang L, Xu K, Ke X, Nervi C, Li Y, Yu L. Int J Cancer; 2017 Feb 01; 140(3):653-661. PubMed ID: 27770540 [Abstract] [Full Text] [Related]
35. Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO. Da Silva N, Meyer-Monard S, Menot ML, Parrado A, Lebel A, Balitrand N, Fenaux P, Micléa JM, Rousselot P, Degos L, Dombret H, Chomienne C. Hematol J; 2000 Feb 01; 1(5):316-28. PubMed ID: 11920209 [Abstract] [Full Text] [Related]
36. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. Gao XN, Lin J, Ning QY, Gao L, Yao YS, Zhou JH, Li YH, Wang LL, Yu L. PLoS One; 2013 Feb 01; 8(2):e55481. PubMed ID: 23390536 [Abstract] [Full Text] [Related]
39. Cooperation between RUNX1-ETO9a and novel transcriptional partner KLF6 in upregulation of Alox5 in acute myeloid leukemia. DeKelver RC, Lewin B, Lam K, Komeno Y, Yan M, Rundle C, Lo MC, Zhang DE. PLoS Genet; 2013 Feb 01; 9(10):e1003765. PubMed ID: 24130502 [Abstract] [Full Text] [Related]
40. YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AML. Chen Z, Shao YL, Wang LL, Lin J, Zhang JB, Ding Y, Gao BB, Liu DH, Gao XN. Oncogene; 2021 Jun 01; 40(22):3786-3798. PubMed ID: 33958724 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]